1-20 of 43
Neha Mehta-Shah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphoma

Clinical Trials & Observations
Jia Ruan, Alison J Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen, Nikita Kotlov, Grigorii Nos, Mr, Maria Sorokina, Vladislav Maksimov, Andrea Sboner, Michael Sigouros, Koen van Besien, Steven M Horwitz, Sarah C. Rutherford, Erin Mulvey, María V. Revuelta, Jenny Z Xiang, Alicia Alonso, Ari M. Melnick, Olivier Elemento, Giorgio GA Inghirami, John P. Leonard, Leandro Cerchietti, Peter Martin
Journal: Blood
Blood blood.2022018254.
DOI: https://doi.org/10.1182/blood.2022018254
Published: 2023
Includes: Supplemental data
Journal Articles

Patterns of Care and Clinical Outcomes in Peripheral T-Cell Lymphomas: The Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (LEO-MER) Prospective Cohort Study

Jia Ruan, Melissa C. Larson, Zhengming Chen, N. Nora Bennani, Pamela B. Allen, David L Jaye, Jonathon B. Cohen, Dai Chihara, Francisco Vega, Giorgio Inghirami, Eric Mou, Carla Casulo, Neha Mehta-Shah, Peter Martin, Matthew J. Maurer, Brad S. Kahl, Izidore S. Lossos, Christopher R. Flowers, James R. Cerhan, Andrew L. Feldman
Journal: Blood
Blood (2022) 140 (Supplement 1): 3666–3668.
DOI: https://doi.org/10.1182/blood-2022-164988
Published: 2022
Journal Articles

Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial Expansion Phase: Impact of Prior Treatment and Expanded Safety Analysis

Eric D Jacobsen, Pier Luigi Zinzani, Jasmine Zain, Monica Mead, Carla Casulo, Giuseppe Gritti, Lauren C. Pinter-Brown, Koji Izutsu, Marci Daugherty, Jonathan E Brammer, Neha Mehta-Shah, Barbara Pro, Steven M. Horwitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 9387–9389.
DOI: https://doi.org/10.1182/blood-2022-169432
Published: 2022
Journal Articles

Mutations Associated with Progression in Follicular Lymphoma Predict Inferior Outcomes in Newly Diagnosed Patients (Alliance 151303)

David A. Russler-Germain, Kilannin Krysiak, Cody Ramirez, Matthew Mosior, Marcus P. Watkins, Felicia Gomez, Zachary Skidmore, Lee Trani, Feng Gao, Susan M. Geyer, Amanda F. Cashen, Neha Mehta-Shah, Brad S. Kahl, Nancy L. Bartlett, Izidore S. Lossos, Eric D. Hsi, Peter Martin, John P. Leonard, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger
Journal: Blood
Blood (2022) 140 (Supplement 1): 3543–3545.
DOI: https://doi.org/10.1182/blood-2022-157051
Published: 2022
Journal Articles

Clonal Evolution of Cutaneous T Cell Lymphoma Revealed at Single Cell Resolution

Hannah Dorando, Jared Andrews, Nicholas Borcherding, Chaz Quinn, Jennifer Schmidt, Jahnavi Aluri, Megan Cooper, Amy C.M. Musiek, Neha Mehta-Shah, Jacqueline E. Payton
Journal: Blood
Blood (2022) 140 (Supplement 1): 754–755.
DOI: https://doi.org/10.1182/blood-2022-163645
Published: 2022
Journal Articles

Dual Immune Checkpoint Agents in Combination with Rituximab for Patients with Relapsed or Refractory Follicular Lymphoma

Reid W Merryman, Robert A. Redd, Arnold S. Freedman, Inhye E. Ahn, Jennifer R. Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Eric D Jacobsen, Austin I. Kim, Ann S. LaCasce, Samuel Ng, Oreofe O. Odejide, Erin Michelle Parry, Iris Isufi, Justin Kline, Jonathon B. Cohen, Neha Mehta-Shah, Nancy L. Bartlett, Matthew Mei, Philippe Armand, Caron A. Jacobson
Journal: Blood
Blood (2022) 140 (Supplement 1): 6531–6533.
DOI: https://doi.org/10.1182/blood-2022-159823
Published: 2022
Journal Articles

Lacutamab in Patients with Advanced Sezary Syndrome: Results from an Interim Analysis of the Tellomak Phase 2 Trial

Martine Bagot, Youn H. Kim, Pablo L. Ortiz-Romero, Pier Luigi Zinzani, Neha Mehta-Shah, Olivier Dereure, Marie Beylot-Barry, Stéphane Dalle, Eric D Jacobsen, Auris Huen, Andrea Combalia, Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Michael S. Khodadoust, Julien Viotti, Christine Paiva, Marianna Muller, Pierluigi Porcu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3760–3761.
DOI: https://doi.org/10.1182/blood-2022-160239
Published: 2022
Journal Articles

CNS Relapse in T-Cell Lymphoma Index: A Risk Score to Predict Central Nervous System Relapse in Patients with T-Cell Lymphomas

Rahul S. Bhansali, Fredrik Ellin, Miao Cao, Thomas Relander, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R Hwang, N. Nora Bennani, Julio C. Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine Zain, Miguel Ruiz, Jonathan E Brammer, Rishab Prakash, Swami P. Iyer, Adam J. Olszewski, Ajay Major, Sonali M. Smith, Peter A. Riedell, Caroline Goldin, Bradley M. Haverkos, Bei Hu, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M Goodman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita Dwivedy Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood
Blood (2022) 140 (Supplement 1): 1481–1484.
DOI: https://doi.org/10.1182/blood-2022-160090
Published: 2022
Journal Articles

The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Hervé Tilly, Franck Morschhauser, Laurie H. Sehn, Jonathan W. Friedberg, Marek Trněný, Jeff P. Sharman, Charles Herbaux, John M. Burke, Matthew Matasar, Shinya Rai, Koji Izutsu, Neha Mehta-Shah, Lucie Oberic, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Richard Greil, Larysa Mykhalska, Juan Miguel Bergua Burgués, Matthew C. Cheung, Antonio Pinto, Ho-Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta Costa, Jyh-Pyng Gau, Jamie Hirata, Yanwen Jiang, Mark Yan, Calvin Lee, Christopher R. Flowers, Gilles Salles
Journal: Blood
Blood (2021) 138 (Supplement 2): LBA-1.
DOI: https://doi.org/10.1182/blood-2021-154729
Published: 2021
Journal Articles

High Rates of Remission with the Initial Treatment of Oral Azacitidine Plus CHOP for Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes and Biomarker Analysis of a Multi-Center Phase II Study

Jia Ruan, Alison J. Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen, Riyaad Rahim, Wei Song, Nikita Kotlov, Grigorii Nos, Vladislav Maksimov, Maria Victoria Revuelta, Andrea Sboner, Michael Sigouros, Koen van Besien, Steven M. Horwitz, Sarah C. Rutherford, Erin C. Mulvey, Morton Coleman, Ari Melnick, Olivier Elemento, Giorgio Inghirami, John P. Leonard, Peter Martin, Leandro Cerchietti
Journal: Blood
Blood (2021) 138 (Supplement 1): 138.
DOI: https://doi.org/10.1182/blood-2021-145495
Published: 2021
Journal Articles

End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-Cell Lymphomas

Neha Mehta-Shah, Eric D Jacobsen, Todd A. Fehniger, Brad S. Kahl, Nancy L. Bartlett, Amanda F. Cashen, Armin Ghobadi, Beth Reagan, Anne Fischer, Alison J. Moskowitz, Fei Wan, Austin Jacobsen, Meredith Olson, Edgar Vigil, Natalie Hill, Karina Elias, Ying Huang, Steven M. Horwitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 3506.
DOI: https://doi.org/10.1182/blood-2021-148768
Published: 2021
Journal Articles

A Phase 1 Study of CFT7455, a Novel Degrader of IKZF1/3, in Multiple Myeloma and Non-Hodgkin Lymphoma

Jesus Berdeja, Sikander Ailawadhi, Steven M. Horwitz, Jeffrey V. Matous, Neha Mehta-Shah, Thomas Martin, Eli Muchtar, Paul G. Richardson, Shambavi Richard, Manisha Bhutani, Andrew J. Yee, Michael R. Palmer, Cathleen Gorman, Oliver Schoenborn-Kellenberger, Sanela Bilic, Adam Crystal, Michelle Mahler, Sagar Lonial
Journal: Blood
Blood (2021) 138 (Supplement 1): 1675.
DOI: https://doi.org/10.1182/blood-2021-153575
Published: 2021
Journal Articles

A Multi-Institutional Retrospective Analysis of T-Cell Lymphomas with Central Nervous System Relapse

Rahul S. Bhansali, Nivetha Ganesan, Robert N. Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R. Hwang, Nora Bennani, Julio C. Chavez, Lubomir Sokol, Hayder Saeed, Priyanka Pullarkat, Neha Mehta-Shah, Rishab Prakash, Swami P. Iyer, Adam J. Olszewski, Caroline Goldin, Brad M. Haverkos, Pamela Allen, Elise A Chong, James N Gerson, Daniel J Landsburg, Sunita Nasta, Stephen J. Schuster, Jakub Svoboda, Stefan K. Barta
Journal: Blood
Blood (2021) 138 (Supplement 1): 1382.
DOI: https://doi.org/10.1182/blood-2021-148868
Published: 2021
Journal Articles

Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Results of an Interim Analysis

Jonathan E Brammer, Pier Luigi Zinzani, Jasmine Zain, Monica Mead, Carla Casulo, Eric D Jacobsen, Giuseppe Gritti, Debra Litwak, David Cohan, Danica J Katz, Neha Mehta-Shah, Barbara Pro, Steven M. Horwitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 2456.
DOI: https://doi.org/10.1182/blood-2021-148939
Published: 2021
Journal Articles

CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas

Margery Gang, Nancy D. Marin, Pamela Wong, Carly C. Neal, Lynne Marsala, Mark Foster, Timothy Schappe, Wei Meng, Jennifer Tran, Maximilian Schaettler, Marco Davila, Feng Gao, Amanda F. Cashen, Nancy L. Bartlett, Neha Mehta-Shah, Brad S. Kahl, Miriam Y. Kim, Matthew L. Cooper, John F. DiPersio, Melissa M. Berrien-Elliott, Todd A. Fehniger
Journal: Blood
Blood (2020) 136 (20): 2308–2318.
DOI: https://doi.org/10.1182/blood.2020006619
Published: 2020
Includes: Supplemental data
Journal Articles

Blinatumomab Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma

Armin Ghobadi, MD, Michael P. Rettig, PhD, Amanda F Cashen, MD, Leah Gehrs, Stephanie Christ, MS, Neha Mehta-Shah, MD, Peter Westervelt, MD PhD, Brad S. Kahl, MD, Nancy L. Bartlett, MD, John F. DiPersio, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
DOI: https://doi.org/10.1182/blood-2020-142464
Published: 2020
Journal Articles

Multi-Center Phase II Study of Oral Azacitidine (CC-486) Plus CHOP As Initial Treatment for Peripheral T-Cell Lymphoma (PTCL)

Jia Ruan, MD PhD, Alison J. Moskowitz, MD, Neha Mehta-Shah, MD, Lubomir Sokol, MD PhD, Zhengming Chen, PhD MPH, MS, Riyaad Rahim, Wei Song, Koen Van Besien, MD PhD, Steven M. Horwitz, MD, Sarah C. Rutherford, MD, Morton Coleman, MD FACP, Ari Melnick, MD, Giorgio Inghirami, MD, Leandro Cerchietti, MD, John P. Leonard, MD, Peter Martin, FRCPC, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
DOI: https://doi.org/10.1182/blood-2020-136023
Published: 2020
Journal Articles

Successful Treatment of Mature T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: The Largest Multicenter Retrospective Analysis

Neha Mehta-Shah, MD, Ajitha Kommalapati, MD, Stephanie Teja, MD, Amanda F Cashen, MD, Parastoo B. Dahi, MD, Craig S. Sauter, MD, Alison J. Moskowitz, MD, Eric D Jacobsen, MD, Basem M. William, MDMRCP, Michael Ozga, MD, Stefan K. Barta, MDMRCP,MS, Alison W. Loren, MD, Steven Bair, MD, Pamela B. Allen, MD MSc, Shahana Sulaiman, Kevin Song, MD, Musa Alzahrani, MBBS, MHSc, Jia Ruan, MD PhD, Koen van Besien, MD PhD, Madhav Seshadri, MD, Matthew McKinney, Anne W. Beaven, MD, Bradley Haverkos, MD MPH, MS, Adam Starr, MD, Onder Alpdogan, MD, Pierluigi Porcu, MD, Francine M. Foss, MD, Yu Tao, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
DOI: https://doi.org/10.1182/blood-2020-138542
Published: 2020
Journal Articles

Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Dose Optimization Efficacy Update and Expansion Phase Initial Results

Barbara Pro, MD, Jonathan E. Brammer, MD, Carla Casulo, MD, Eric Jacobsen, MD, Monica Mead, MD BS, Neha Mehta-Shah, MD, Jasmine M. Zain, MD, Pier Luigi Zinzani, MD, Stephanie Lustgarten, PhD, Hagop Youssoufian, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
DOI: https://doi.org/10.1182/blood-2020-140412
Published: 2020
Journal Articles

A Phase I Study of Anti-ICOS Antibody MEDI-570 for Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Angioimmunoblastic T-Cell Lymphoma (AITL) (NCI-9930)

Julio C. Chavez, MD, Francine M. Foss, MD, Basem M. William, MDMRCP, Jonathan E Brammer, MD, Sonali M. Smith, MD, Anca Prica, MD, Jasmine M. Zain, MD, Joseph M Tuscano, MD, Martha Glenn, MD, Neha Mehta-Shah, MD, Ben X Wang, Stephanie Zantinge, Lisa Wang, Ling Zhang, MD, Anmarie Boutrin, Weiguang Zhao, Lily Cheng, Nathan Standifer, Gianluca Carlesso, Jeffrey Moscow, Lillian Siu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
DOI: https://doi.org/10.1182/blood-2020-136465
Published: 2020